PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGlioblastomas may be fuelled by overactive mitochondria

BioNews

Glioblastomas may be fuelled by overactive mitochondria

Published 14 January 2021 posted in News and appears in BioNews 1079
PET BioNews

Existing drugs could treat as many as one in five glioblastomas, a new study has found...

Existing drugs could treat as many as one in five glioblastomas, a new study has found.

Glioblastomas are the most common primary brain cancer in adults, with an average survival time of 15 months. Current research based on genetic classification of these cancers has so far yielded little improvement to this prognosis. Building on previous attempts to categorise glioblastomas, the researchers at Columbia University, New York used metabolic analysis to shed new light on what helps these cancers grow. Not only does this work show what makes these cancers so aggressive, but also that some may be effectively treated with drugs already in development.

'Existing classifications for brain cancer are not informative. They don't predict outcomes; they don't tell us which treatments will work best,' said Dr Anna Lasorella, who led the research. Professor Antonio Iavorone, co-lead of the study, added: 'We feel that one of the reasons therapeutic progress in brain cancer has been so slow is because we don't have a good way to classify these tumours.'

The study, published in Nature Cancer, used single-cell analysis technology to look at the underlying biological processes in 17,367 individual cells from 36 different tumours. Using computational analysis, the scientists were able to define four categories of glioblastoma based on their core cellular functions.

Professor Iavarone explained: 'In this way, we can classify each individual tumour cell based on the real biology that sustains them.'

One of these categories, which the researchers termed 'mitochondrial glioblastomas', is fuelled by the energy generated by overactive mitochondria. The team found that this activity could be dampened using mitochondrial inhibitors currently in clinical trials, slowing the growth of these cancer cells.

'We can now expand these clinical trials to a much larger group of patients, because we can identify patients with mitochondria-driven tumours, regardless of the underlying genetics,' explained Professor Iavorone.

While the mitochondrial group already shows some promise of possible treatment, the discovery of the other three categories offers hope for the treatment of more cases of glioblastoma. The researchers are also applying this principle to a broader range of tumours, in the hope that they may reveal previously unnoticed similarities. This could allow successful treatments to be used to treat different cancers with similar metabolic characteristics.

'When we classify based on the cell's core biological activities, which all cells rely on to survive and thrive, we may find that cancers share more in common than was previously apparent by just looking at their genes,' said Dr Lasorella.

Sources and References

  • 11/01/2021
    Nature Cancer
    Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
  • 11/01/2021
    Columbia University Irving Medical Center
    One in five brain cancers fueled by overactive mitochondria
  • 12/01/2021
    Genetic Engineering and Biotechnology News
    Mitochondria in overdrive linked to glioblastomas

Related Articles

PET BioNews
News
23 May 2022 • 2 minutes read

Pre-made stem cells to treat aggressive brain cancer

by Sneha Krishnamurthy

A new form of stem cell-based therapy has been developed and tested in mice for the treatment of glioblastoma, a highly aggressive form of brain cancer...

PET BioNews
News
10 September 2021 • 1 minute read

Mitochondrial sensors highlight the role of exercise in avoiding chronic disease

by Bethany Muller

New research detailing how mitochondria maintain proper function could lead to improved treatments for conditions such as Alzheimer's and diabetes...

PET BioNews
News
4 February 2021 • 2 minutes read

Mitochondrial defects may lead to autism

by Jennifer Frosch

Autism spectrum disorder may result from mild defects in the mitochondria of brain cells, early research in mice has shown...

PET BioNews
News
27 November 2020 • 2 minutes read

Space travel impairs mitochondrial function

by Dr Alexander Ware

Spaceflight is hard on the human body, and our mitochondria are not immune to its pressures...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
17 August 2018 • 3 minutes read

Elephants' 'zombie gene' may give cancer insights

by Dr Loredana Guglielmi

For their large body size, elephants should get cancer a lot more often than they do — now a new study has found out why...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Controlling the immune system with 'invisible stem' cells

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856